We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-10 of 118

Pregnancy as a Disability? Khan v. Midwestern University
  • Husch Blackwell LLP
  • USA
  • June 13 2017

Ayesha Khan enrolled as a medical student at Midwestern University in fall 2010. 3.5 years into the program, in early 2013, Ms. Khan became pregnant

Italian Competition Authority Opens Sector Inquiry on Vaccines Competition
  • Jones Day
  • European Union, Italy
  • July 18 2016

Over the last few years the pharmaceutical industry in Italy has attracted increasingly intensive antitrust scrutiny. Last month the Italian

Genetic Discrimination and Canadian Law
  • Borden Ladner Gervais LLP
  • Canada
  • July 8 2016

A number of national governments for example, in the United States, Australia and a number of European countries have taken legislative action to

Proposed Senate Bill to Expand Certified Nurse Anesthetist Scope of Practice
  • Hall Render Killian Heath & Lyman PC
  • USA
  • June 29 2016

On June 7, 2016, a bill expanding the scope of practice for certified nurse anesthetists (“NAs”) was introduced to the Michigan Senate by Sen. Mike

E-cigarettes no longer considered medicinal products in Sweden
  • Advokatfirman Lindahl
  • Sweden
  • May 25 2016

The Supreme Administrative Court has ruled that e-cigarettes not marketed for smoking cessation purposes should not be classified as medicinal

Update on Turkish Food Codex Regulation on Classification of Pharmacological Active Agents for Animal Products and Maximum Residue Levels are published on the Official Gazette
  • Güzeloğlu Attorneys-at-law
  • Turkey
  • February 15 2016

Ministry of Food, Agriculture and Livestock has amended the Turkish Food Codex Regulation on Classification of Pharmacological Active Agents for

Actavis v Eli Lilly
  • AA Thornton & Co
  • United Kingdom
  • February 5 2016

An often-used argument when seeking revocation of a patent, where it is alleged that the patent discloses little more than the prior art, is that the

OPDP warns Otsuka over improper marketing of antipsychotic drug Abilify
  • Loeb & Loeb LLP
  • USA
  • May 31 2015

Otsuka received a warning letter after an FDA review of its pharmacology aid for its Abilify tablets showed the company made false or misleading

Energy drink maker commissions scientific white paper on ingredient safety
  • Shook Hardy & Bacon LLP
  • USA
  • April 5 2013

Las Vegas, Nevada-based Rockstar, Inc. recently released a "scientific white paper" prepared for the energy drink maker by Intertek Cantox. Signed by

Draft regulation on clinical trials - abolishment of obligatory insurance
  • Bird & Bird
  • European Union
  • February 25 2013

In July 2012 the European Commission published its proposal for a "Regulation on clinical trials on medicinal products for human use" (COM 2012 369